Greg M. Arndt

1.7k total citations
45 papers, 1.2k citations indexed

About

Greg M. Arndt is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Greg M. Arndt has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 5 papers in Public Health, Environmental and Occupational Health and 5 papers in Hematology. Recurrent topics in Greg M. Arndt's work include RNA Interference and Gene Delivery (8 papers), CRISPR and Genetic Engineering (8 papers) and Fungal and yeast genetics research (8 papers). Greg M. Arndt is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), CRISPR and Genetic Engineering (8 papers) and Fungal and yeast genetics research (8 papers). Greg M. Arndt collaborates with scholars based in Australia, United States and Canada. Greg M. Arndt's co-authors include Lara M. Cullen, Karen L. MacKenzie, Mitch Raponi, Nham Tran, David Atkins, Lesley Dossey, Hongtao Fan, Anton Bittner, Angela Lai and Chunyan Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Greg M. Arndt

45 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Greg M. Arndt Australia 18 873 295 165 134 98 45 1.2k
Brian O. Bodemann United States 11 1.2k 1.4× 163 0.6× 216 1.3× 171 1.3× 57 0.6× 11 1.5k
Russell Bell United States 19 1.1k 1.3× 140 0.5× 199 1.2× 133 1.0× 44 0.4× 29 1.7k
Ruud H. Wijdeven Netherlands 16 686 0.8× 94 0.3× 180 1.1× 192 1.4× 111 1.1× 31 1.3k
Susan Fong United States 15 675 0.8× 227 0.8× 173 1.0× 270 2.0× 27 0.3× 19 1.2k
Shuraila F. Zerp Netherlands 19 1.0k 1.2× 135 0.5× 365 2.2× 106 0.8× 61 0.6× 28 1.4k
H. Christian Eberl Germany 17 1.5k 1.7× 99 0.3× 130 0.8× 218 1.6× 38 0.4× 27 1.7k
Borlan Pan United States 15 1.2k 1.3× 199 0.7× 311 1.9× 404 3.0× 35 0.4× 23 1.6k
Peter Goettig Germany 24 882 1.0× 336 1.1× 625 3.8× 130 1.0× 62 0.6× 44 1.6k
Shiro Soga Japan 16 1.0k 1.2× 71 0.2× 132 0.8× 202 1.5× 47 0.5× 26 1.2k
Joseph Lee United States 17 1.7k 1.9× 144 0.5× 305 1.8× 75 0.6× 62 0.6× 31 1.9k

Countries citing papers authored by Greg M. Arndt

Since Specialization
Citations

This map shows the geographic impact of Greg M. Arndt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg M. Arndt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg M. Arndt more than expected).

Fields of papers citing papers by Greg M. Arndt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg M. Arndt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg M. Arndt. The network helps show where Greg M. Arndt may publish in the future.

Co-authorship network of co-authors of Greg M. Arndt

This figure shows the co-authorship network connecting the top 25 collaborators of Greg M. Arndt. A scholar is included among the top collaborators of Greg M. Arndt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg M. Arndt. Greg M. Arndt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Teo, Wee Siang, Tanya Dwarte, Estrella Gonzales‐Aloy, et al.. (2022). βIII‐tubulin suppression enhances the activity of Amuvatinib to inhibit cell proliferation in c‐Met positive non‐small cell lung cancer cells. Cancer Medicine. 12(4). 4455–4471. 3 indexed citations
2.
Bingül, Murat, Greg M. Arndt, Glenn M. Marshall, et al.. (2021). Synthesis and Characterisation of Novel Tricyclic and Tetracyclic Furoindoles: Biological Evaluation as SAHA Enhancer against Neuroblastoma and Breast Cancer Cells. Molecules. 26(19). 5745–5745. 2 indexed citations
3.
Mariana, Anna, Andrew J. Gifford, Ursula R. Kees, et al.. (2021). Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin. British Journal of Cancer. 125(1). 55–64. 16 indexed citations
4.
Bingül, Murat, Greg M. Arndt, Glenn M. Marshall, et al.. (2020). Synthesis, Characterization and Biological Evaluation of Novel Dihydropyranoindoles Improving the Anticancer Effects of HDAC Inhibitors. Molecules. 25(6). 1377–1377. 4 indexed citations
5.
Kamili, Alvin, Andrew J. Gifford, Nancy Li, et al.. (2020). Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy. British Journal of Cancer. 122(5). 680–691. 32 indexed citations
6.
Bryce, Nicole S., Justine Stehn, Stefan Zahler, et al.. (2019). High-Content Imaging of Unbiased Chemical Perturbations Reveals that the Phenotypic Plasticity of the Actin Cytoskeleton Is Constrained. Cell Systems. 9(5). 496–507.e5. 12 indexed citations
7.
Cruickshank, Mark N., Jette Ford, Laurence C. Cheung, et al.. (2016). Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsin. Leukemia. 31(1). 40–50. 18 indexed citations
8.
Cheung, Leanna, et al.. (2014). Identification of new MRP4 inhibitors from a library of FDA approved drugs using a high-throughput bioluminescence screen. Biochemical Pharmacology. 93(3). 380–388. 27 indexed citations
9.
Arndt, Greg M., et al.. (2014). High-Throughput Screening of Human Leukemia Xenografts to Identify Dexamethasone Sensitizers. SLAS DISCOVERY. 19(10). 1391–1401. 3 indexed citations
10.
Failes, Timothy W., et al.. (2013). Synthesis and anticancer evaluation of 3-substituted quinolin-4-ones and 2,3-dihydroquinolin-4-ones. Bioorganic & Medicinal Chemistry. 22(1). 105–115. 18 indexed citations
11.
Passioura, Toby, Amber Goodchild, Andrew King, et al.. (2009). Interfering ribonucleic acids that suppress expression of multiple unrelated genes. BMC Biotechnology. 9(1). 57–57. 2 indexed citations
12.
Tanudji, Marcel, Dorothy A. Machalek, Greg M. Arndt, & Laurent P. Rivory. (2009). Competition Between siRNA Duplexes: Impact of RNA-Induced Silencing Complex Loading Efficiency and Comparison Between Conventional-21 bp and Dicer-Substrate siRNAs. Oligonucleotides. 20(1). 27–32. 17 indexed citations
13.
Lai, Angela, Murray J. Cairns, Nham Tran, et al.. (2009). RNA Modulators of Complex Phenotypes in Mammalian Cells. PLoS ONE. 4(3). e4758–e4758. 3 indexed citations
14.
Burgess, Janette K., Stephen M. Carlin, Greg M. Arndt, et al.. (2004). Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: A possible role in asthma?. Journal of Allergy and Clinical Immunology. 113(4). 683–689. 75 indexed citations
15.
Tran, Nham, Mitch Raponi, Ian W. Dawes, & Greg M. Arndt. (2004). Control of specific gene expression in mammalian cells by co‐expression of long complementary RNAs. FEBS Letters. 573(1-3). 127–134. 15 indexed citations
16.
Tran, Nham, Murray J. Cairns, Ian W. Dawes, & Greg M. Arndt. (2003). Expressing functional siRNAs in mammalian cells using convergent transcription. BMC Biotechnology. 3(1). 21–21. 35 indexed citations
17.
Backer, Marianne D. De, Mitch Raponi, & Greg M. Arndt. (2002). RNA-mediated gene silencing in non-pathogenic and pathogenic fungi. Current Opinion in Microbiology. 5(3). 323–329. 23 indexed citations
18.
Raponi, Mitch, David Atkins, Ian W. Dawes, & Greg M. Arndt. (2000). The Influence of Antisense Gene Location on Target Gene Suppression in the Fission Yeast Schizosaccharomyces pombe. Antisense and Nucleic Acid Drug Development. 10(1). 29–34. 8 indexed citations
19.
Arndt, Greg M., et al.. (1997). Colocalization of antisense RNAs and ribozymes with their target mRNAs. Genome. 40(6). 785–797. 21 indexed citations
20.
Arndt, Greg M., David Atkins, Margaret Patrikakis, & Jonathan G. Izant. (1995). Gene regulation by antisense RNA in the fission yeastSchizosaccharomyces pombe. Molecular and General Genetics MGG. 248(3). 293–300. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian O. Bodemann Breakdown of academic impact, for papers by Russell Bell Breakdown of academic impact, for papers by Ruud H. Wijdeven Breakdown of academic impact, for papers by Susan Fong Breakdown of academic impact, for papers by Shuraila F. Zerp Breakdown of academic impact, for papers by H. Christian Eberl Breakdown of academic impact, for papers by Borlan Pan Breakdown of academic impact, for papers by Peter Goettig Breakdown of academic impact, for papers by Shiro Soga Breakdown of academic impact, for papers by Joseph Lee
Rankless by CCL
2026